|$452,335||To examine trends in prescription drug prices and Medicare Part D formulary coverage and broadly disseminate the findings policy briefs, papers, and convenings.||2018 - 2020||LJAF|
|$200,000||To support Kaiser Health News in providing independent reporting on pharmaceutical drug development and pricing.||2017 - 2018||LJAF|
|$423,447||To provide researchers, policymakers, and the public with accessible, unbiased information about the Medicaid pharmacy benefit and policy options to lower Medicaid drug spending.||2019 - 2021||LJAF|
|$998,090||To produce nonpartisan, educational analyses, policy briefs, and explainers examining the effect of proposed health policy changes on prices, costs and affordability.||2019 - 2022||LJAF|
|$1,060,500||To support Kaiser Health News in providing independent reporting on pharmaceutical drug development and pricing.||2016 - 2018||LJAF|
|$1,000,000||To provide general operating support for Kaiser Health News||2020 - 2021||LJAF|
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.